TXU (anti-CD7)-pokeweed antiviral protein as a potent inhibitor of human immunodeficiency virus
In: Antimicrobial agents and chemotherapy, Jg. 42 (1998), Heft 2, S. 383-388
Online
academicJournal
- print, 23 ref
Zugriff:
We have evaluated the clinical potential of TXU (anti-CD7)-pokeweed antiviral protein (PAP) immunoconjugate (TXU-PAP) as a new biotherapeutic anti-human immunodeficiency virus (anti-HIV) agent by evaluating its anti-HIV type 1 (anti-HIV-1) activity in vitro, as well as in a surrogate human peripheral blood lymphocyte-severe combined immunodeficient (Hu-PBL-SCID) mouse model of human AIDS. The present report documents in a side-by-side comparison the superior in vitro anti-HIV-1 activity of TXU-PAP compared to the activities of zidovudine, 2',3'-didehydro-2',3'-dideoxythymidine, unconjugated PAP, and B53-PAP, an anti-CD4-PAP immunoconjugate. Notably, TXU-PAP elicited potent anti-HIV activity in the Hu-PBL-SCID mouse model of human AIDS without any side effects and at doses that were very well tolerated by cynomolgus monkeys. Furthermore, plasma samples from TXU-PAP-treated cynomolgus monkeys showed potent anti-HIV-1 activity in vitro.
Titel: |
TXU (anti-CD7)-pokeweed antiviral protein as a potent inhibitor of human immunodeficiency virus
|
---|---|
Autor/in / Beteiligte Person: | UCKUN, F. M ; CHELSTROM, L. M ; TUEL-AHLGREN, L ; DIBIRDIK, I ; IRVIN, J. D ; LANGLIE, M.-C ; MYERS, D. E |
Link: | |
Zeitschrift: | Antimicrobial agents and chemotherapy, Jg. 42 (1998), Heft 2, S. 383-388 |
Veröffentlichung: | Washington, DC: American Society for Microbiology, 1998 |
Medientyp: | academicJournal |
Umfang: | print, 23 ref |
ISSN: | 0066-4804 (print) |
Schlagwort: |
|
Sonstiges: |
|